Acquisition Synergy Hologics ownership enables cross-selling and distribution expansion across molecular diagnostics and epigenomics services, unlocking faster access to clinical labs, biotech customers, and CROs.

RNA Sequencing Growth D Plex Small RNA kit launch signals expansion into targeted RNA sequencing; opportunity to upsell end to end library preparation, sequencing capacity, and data analysis services to NGS labs, pharmaceutical groups, and academic researchers, aligned with an integrated DNBSEQ platform.

European Footprint Belgian base in Europe offers entry points to regional biotech clusters, universities, and CROs; potential to expand through partnerships and co marketing with a localized sales motion.

Integrated Workflows Capabilities across epigenomics and proteomics sample preparation enable bundled service offerings and end to end workflows; room to partner with proteomics ecosystem players and MS labs for combined solutions.

Growth Capacity Moderate scale with external funding suggests the ability to scale services, invest in new kits, and pursue longer term contracts with SMBs and academic labs seeking cost effective epigenomics and sample preparation solutions.